. Nitric oxide attenuates insulin-or IGF-I-stimulated aortic smooth muscle cell motility by decreasing H2O2 levels: essential role of cGMP. Am J Physiol Heart Circ Physiol 286: H2103-H2112, 2004. First published January 29, 2004 10.1152/ajpheart.01118.2003.-Insulin and insulin-like growth factor I (IGF-I) both play important roles in vascular remodeling. Moreover, nitric oxide (NO) is well established as a counterregulatory agent that opposes the actions of several vascular agonists, in part by decreasing smooth muscle motility. We tested the hypothesis that NO blocks insulin or IGF-I-induced rat aortic smooth muscle cell motility via a mechanism involving the attenuation of agonist-induced elevation of hydrogen peroxide levels and cGMP as mediator. Insulin or IGF-I induced an increase of hydrogen peroxide levels and cell motility. Both effects were blocked by catalase or diphenyleneiodonium, indicating that hydrogen peroxide elevation is necessary for induction of cell motility. Two NO donors mimicked the effects of catalase, indicating that NO decreases cell motility by suppressing agonist-induced elevation of hydrogen peroxide. A cGMP analogue mimicked the effect of NO, whereas a guanyl cyclase inhibitor blocked the effect of NO on hydrogen peroxide levels, indicating that elevation of cGMP is both necessary and sufficient to account for the reduction of hydrogen peroxide levels. A NO donor as well as a cGMP analogue attenuated insulin-stimulated NADPH activity, indicating that NO decreases hydrogen peroxide levels by inhibiting the generation of superoxide, via a cGMP-mediated mechanism. Finally, exogenous hydrogen peroxide increased cell motility and reversed the inhibitory effect of cGMP. These results support the view that NO plays an antioxidant role via reduction of hydrogen peroxide in cultured rat aortic smooth muscle cells and that this effect is both necessary and sufficient to account for its capacity to decrease cell motility. vascular remodeling; antioxidant; Akt; NAD(P)H oxidase TYPE 2 DIABETES CONSTITUTES a major risk factor for the pathogenesis of vascular disease (19). It is also well established that diabetes increases the frequency of coronary vessel restenosis after therapeutic angioplasty (46). Most forms of vascular disease in conduit arteries manifest neointimal enlargement, and although Type 2 diabetes is associated with hyperglycemia as well as hyperinsulinemia, recent studies (20, 44) suggest that elevated insulin levels may be the more important factor in the pathogenesis of diabetic neointimal enlargement.
TYPE 2 DIABETES CONSTITUTES a major risk factor for the pathogenesis of vascular disease (19) . It is also well established that diabetes increases the frequency of coronary vessel restenosis after therapeutic angioplasty (46) . Most forms of vascular disease in conduit arteries manifest neointimal enlargement, and although Type 2 diabetes is associated with hyperglycemia as well as hyperinsulinemia, recent studies (20, 44) suggest that elevated insulin levels may be the more important factor in the pathogenesis of diabetic neointimal enlargement.
A functional role of insulin-like growth factor I (IGF-I) in neointima formation has also been proposed based on the decrease of neointima formation in rats treated with an IGF-I antagonist and the increase of neointima formation in transgenic mice, overexpressing IGF-I specifically in blood vessels (49, 50) . In addition, IGF-I gene expression is upregulated in medial vascular smooth muscle cells after balloon injury, at a time corresponding to increased DNA synthesis (21) .
Several polypeptide growth factors increase the levels of hydrogen peroxide in vascular smooth muscle cells, and this effect appears to be necessary for induction of cell proliferation and migration (1, 43) . The capacity of growth factors to increase hydrogen peroxide is linked primarily to activation of NAD(P)H oxidase, which generates superoxide anion, followed by enzymatic conversion of superoxide to hydrogen peroxide by superoxide dismutase (15) . Hydrogen peroxide is then degraded by catalase and glutathione peroxidase to water. NAD(P)H oxidase is upregulated after vascular injury, and this effect may play an important role in the generation of a neointima (40, 45) .
Antioxidants have the capacity to attenuate neointima formation, supporting the view that reactive oxygen species are important in the pathogenesis of vascular disease (38) . In cultured smooth muscle cells, hydrogen peroxide induces tyrosine phosphorylation of growth factor receptor kinases and activation of downstream effectors, such as Ras or mitogenactivated protein (MAP) kinase, consistent with a putative role of this oxidant in regulation of mechanisms thought to be associated with vascular remodeling (33) . Catalase blocks PDGF-induced hydrogen peroxide generation, MAP kinase activation and proliferation in cultured vascular smooth muscle cells, consistent with an essential role of hydrogen peroxide in signaling and proliferation (43) . Moreover, the inhibitory effect of catalase in vivo supports the view that hydrogen peroxide itself plays an important role in regulation of vascular remodeling (3) .
Exogenous NO or NO generated by the endothelium or by vascular smooth muscle cells decreases vascular smooth muscle cell motility and proliferation as well as neointima formation in various models of vascular injury (37, 47) . However, the mechanisms underlying the antimitogenic and antimotogenic effects of NO are incompletely understood. Previous studies (23, 39) have reported that NO can attenuate signal transduction pathways involving MAP kinases or the cell cycle. We have reported that NO upregulates the activity of a tyrosine phosphatase, PTP1B, that targets insulin-stimulated signal transduction and cell motility in cultured vascular smooth muscle cells (18) . Because hydrogen peroxide appears to be a second messenger that regulates cell motility, it seems likely that NO may also target mechanisms regulating hydrogen peroxide generation. Indeed, recent studies (7, 12) have found that NO can attenuate the capacity of neutrophils to generate superoxide by directly interacting with NAD(P)H oxidase. NO can also reduce superoxide levels by directly reacting with superoxide and forming peroxynitrite (36) .
The aforementioned findings prompted us to test several hypotheses related to the motogenic effect of insulin or IGF-I, as well as the antimotogenic effect of NO in cultured rat aortic smooth muscle cells. First, we tested the hypothesis that insulin and IGF-I have the capacity to increase hydrogen peroxide levels and that this effect is necessary for induction of cell motility. Second, we tested the hypothesis that NO attenuates insulin-or IGF-I-induced hydrogen peroxide elevation via a cGMP-mediated mechanism that induces inhibition of NAD(P)H oxidase activity. Third, we tested the hypothesis that the capacity of NO to decrease insulin receptor (IR) or IGF-I receptor tyrosine phosphorylation levels can be explained by attenuation of agonist-induced increase of hydrogen peroxide levels. Finally, we tested the hypothesis that the capacity of NO to attenuate hydrogen peroxide levels is sufficient and necessary to explain NO-induced inhibition of cell motility.
MATERIALS AND METHODS

Materials.
Lactating female rats of the Sprague-Dawley strain and their pups were purchased from Charles River Laboratories (Wilmington, MA), or pups of the same strain were bred in the University of Tennessee vivarium. Primaria tissue culture plates were from Falcon/ Becton Dickinson (Oxnard, CA). Type I collagenase, soybean trypsin inhibitor, fetal bovine serum, bovine serum albumin (fraction V), catalase, 1H- [1, 2, 4] oxadiozolo [4,3-a] quinoxalin-1-one (ODQ), NADPH, diphenylene iodonium (DPI), or lucigenin were from Sigma (St. Louis, MO). 2,2-(Hydroxynitrosohydrazino) bis-ethanamine (DETANO) and S-nitroso-N-acetyl-penicillamine (SNAP) were obtained from Alexis Biochemicals (Carlsbad, CA). DMEM-Ham's F-12 (1:1) was from GIBCO (Grand Island, NY). Porcine pancreatic elastase, insulin, transferrin, and selenous acid were from Collaborative Research (Lexington, MA). Antibodies against phosphotyrosine [RC20H AntiPTyr-horseradish peroxidase (HRP)] were from Transduction Laboratories (Lexington, KY). Antibodies against IR or IGF-I receptor were from Santa Cruz Biotechnology (Santa Cruz, CA), whereas the antibody against Akt was from Cell Signaling (Beverly, MA). All other reagents were of the highest quality available and were generally obtained from Sigma (St. Louis, MO) or Baxter (Edison, NJ), unless stated otherwise.
Cell culture. Smooth muscle cells were obtained from the thoracic aortas of newborn Sprague-Dawley rats (6 -9 days old) and cultured as previously described (42) . All experiments in this study were performed using primary cultures; moreover, each individual experiment represents results from one such cell isolate, generally obtained from two newborn rat litters. All experiments were done using confluent cultures that were serum starved for 24 -48 h before experiments. The current studies were performed via a protocol approved by the Animal Care and Use Committee, University of Tennessee Health Science Center, in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 86-23, Revised 1996) .
Measurement of intracellular hydrogen peroxide levels. Intracellular hydrogen peroxide levels were detected by measurement of the fluorescence of oxidized DCF, as described (1) . Most experiments were done by preincubation of serum-starved primary cultures with various antagonists (30 M DETANO or 50 M SNAP for 30 min, 1 mM N-acetylcysteine for 90 min, or 0.3 M catalase for 3 h), followed by incubation with agonists (insulin for 5 min, IGF-I for 30 s). DCF was loaded by incubation of cells for the last 10 min of the preincubation period with 10 M DCF/diacetate. Excess DCF was removed by being washed three times with Hanks' balanced salt solution, followed by measurement of epifluorescence levels in a Nikon microscope equipped with an FITC filter (excitation wavelength 488 nm, emission wavelength 515-540 nm) and a Coolsnap digital camera (Photometrics; Tucson, AZ). Fluorescence images were collected via a single rapid scan (5-10 s) to avoid photobleaching and quantitation was performed via the MetaMorph software (Universal Imaging; West Chester, PA). Care was taken to maintain camera settings and acquisition times constant for all treatment categories. All values had an appropriate background subtracted before analysis of DCF fluorescence.
Immunoprecipitation and immunoblotting. Cells were lysed in RIPA buffer (150 mM NaCl, 1% sodium deoxycholate, 0.1% SDS, 1% Triton X-100, and 50 mM Tris, pH 7.2) containing 2 mM sodium vanadate, 1 mM PMSF, 5 g/ml aprotinin, and 5 g/ml leupeptin. Protein concentration in lysates was determined by the bicinchoninic acid method. Immunoprecipitation was performed by incubation of cell lysates (ϳ2 mg protein equivalent) with antibodies directed against IR-␤ subunit or IGF-IR (4 g protein equivalent), for 3 h at 4°C, followed by the addition of protein G-Sepharose beads (Pharmacia) and further incubation for 2 h at 4°C. Sepharose beads were then washed twice with the above-mentioned buffer and once with 50 mM Tris buffer (pH 7.2) containing 150 mM NaCl, 1 mM sodium vanadate, and 1 mM PMSF, followed by boiling of beads in Laemmli sample buffer and loading of supernatant onto gels for SDS-PAGE. Proteins were transferred onto polyvinylidene difluoride membranes (Immobilon PVDF, Millipore), followed by a probe with anti-phosphotyrosine (RC20H Anti-PTyr-HRP) antibodies (1:5,000). The blots were then stripped and reprobed with primary antibodies directed against IR-␤ (1:500), IGF-IR (1:500), or Akt (1:1,000), followed by HRP-coupled secondary antibodies with appropriate specificity. Immunoreactive bands were visualized using Western Lightning Chemiluminescence Reagents Plus (Perkin-Elmer).
Measurement of NADPH oxidase activity via chemiluminescence assay. NADPH oxidase activity was measured via lucigenin chemiluminescence assay, based on the finding that relatively low concentrations of lucigenin, of the order of 5-10 M, allow specific measurement of superoxide levels (28, 41) . Cells were treated with experimental agents, followed by a gentle washing with ice-cold PBS, scraping, and trituration with the use of a 26-gauge needle, based on a procedure described by Parinandi et al. (30) . The cell suspension was kept on ice. An aliquot of cell lysate (200 l, corresponding to ϳ10 6 cells) was added to prewarmed PBS containing 10 M lucigenin and with or without 50 M NADPH, containing or lacking the NADPH oxidase inhibitor DPI and chemiluminescence was measured in a Packard scintillation counter in which the coincidence circuit was turned off. Chemiluminescence was measured for 3 min and NADPH oxidase activity was expressed as counts per minute per million cells.
Measurement of cell motility. Cell motility was measured via a monolayer wounding assay, involving migration of cells into the breach, as described by Chang et al. (5) . All experiments were done in the presence of hydroxyurea, to prevent cell proliferation, as described previously (5) . The motility index was expressed as the distance migrated in 24 h.
Data analysis. Data are expressed as means Ϯ SE and statistically evaluated using Student's paired t-test, one-or two-way ANOVA of the raw data, followed by Fisher's test. P Ͻ 0.05 was considered to be significant.
RESULTS
Insulin stimulates rat aortic smooth muscle cell motility via a mechanism independent of IGF-I receptor activation. In a previous study (42), we showed that insulin has the capacity to induce cell motility in cultured aortic smooth muscle cells isolated from newborn rats. In the current study, we show that IGF-I also has the capacity to stimulate cell motility, to about the same extent as insulin (Fig. 1) . This raises the issue of whether the effect of insulin is mediated via the IGF-I receptor (IGF-IR) rather than the IR. To address this possibility, we used an antibody that has been reported to block the IGF-I receptor in rat aortic smooth muscle cells in selective fashion (2) . As shown in Fig. 1 , anti-IGF-IR failed to alter the motilitystimulatory effect of insulin, although it attenuated IGF-Iinduced motility by Ͼ80%. This indicates that the motilitystimulatory effect of insulin is unlikely to occur via stimulation of the IGF-IR.
Insulin or IGF-I induces hydrogen peroxide elevation in cultured rat aortic smooth muscle cells. Previous studies (26) have found that insulin has the capacity to increase hydrogen peroxide levels in adipocytes, via a process that can be inhibited by the NAD(P)H oxidase inhibitor DPI. However, the capacity of either insulin or IGF-I to increase hydrogen peroxide levels in vascular smooth muscle does not seem to have been investigated. We were therefore prompted to determine the effect of insulin or IGF-I on hydrogen peroxide levels in cultured primary rat aortic smooth muscle cells. To measure hydrogen peroxide levels, we used a well-established reporter agent, 2Ј,7Ј-dichlorodihydrofluorescein (DCF), which is sensitive to the oxidizing activity of hydrogen peroxide. Figure 2 shows the time course for insulin-or IGF-I-induced oxidation of DCF. The time courses of these effects were somewhat different for these agonists, inasmuch as the effect of insulin appeared transient, peaking within a few minutes, followed by a decline to baseline after 30 min ( Fig. 2A) . In contrast, IGF-I also induced a partially transient increase, followed by a sustained increase that continued to be manifested for at least 5 h (Fig. 2B) .
Catalase attenuates the capacity of insulin or IGF-I to increase hydrogen peroxide levels. As reported by others (43) , catalase is an enzyme that specifically metabolizes hydrogen peroxide to water and oxygen and that is used to decrease hydrogen peroxide levels in vascular smooth muscle cells.
Thus reduction of hydrogen peroxide levels by catalase is considered a diagnostic tool for the assay of hydrogen peroxide in cultured cells. To verify the selectivity of DCF as indicator of hydrogen peroxide levels, we pretreated the cells with catalase. As shown in Fig. 3 , catalase abolished the capacity of insulin to induce oxidation of DCF and inferrentially to increase hydrogen peroxide levels. Similar results were obtained in cells stimulated with IGF-I (two experiments, results not shown). Boiled catalase was completely ineffective (two experiments, not shown). An antioxidant, N-acetylcysteine, also abolished the increase of hydrogen peroxide levels induced by insulin (Fig. 3) , presumably by increasing the levels of reduced endogenous glutathione (31) .
NO or a cGMP analog attenuates the increase of hydrogen peroxide levels induced by insulin or IGF-I. We next tested the hypothesis that NO could attenuate the increase of hydrogen peroxide levels induced by insulin or IGF-I. The results given in Fig. 4A show the fluorescence levels of cells under the microscope, in response to various agents. As depicted, insulin markedly increased DCF fluorescence levels, whereas NO donor attenuated this effect. Results shown in Fig. 4 , B and C, provide the quantitative summary of all such experiments, using insulin or IGF-I as the agonist, and they indicate that NO donors blocked the effect of either agonist. On the other hand, treatment of cells with NO donors alone failed to induce a statistically significant change of hydrogen peroxide levels. Because peroxynitrite has been reported to induce oxidation of DCF (22) , the lack of an effect of NO alone indicates that NO donors are unlikely to induce an increase of peroxynitrite levels in our cells.
To test the hypothesis that the inhibitory effect of NO is mediated via increased cGMP, we treated cells with insulin, in the presence or absence of a cGMP analog, 8-(4-chlorophenylthio) (8-p-CPT)-cGMP. Results given in Fig. 4, A and B, indicate that, similar to the effect of NO donors, the cGMP analogue blocked the capacity of insulin to increase hydrogen peroxide levels, supporting the view that increased cGMP is sufficient to mediate the inhibitory effect of NO. Moreover, the effect of cGMP further supports the view that the effect of NO is independent of its capacity to lower superoxide levels via the reaction of NO with superoxide to form peroxynitrite because there is no known direct interaction of cGMP and superoxide.
It should also be noted that the magnitude of the fluorescence increase induced by insulin or IGF-I differed somewhat between experiments, ranging from ϳ3-fold to ϳ8-fold above basal levels, due to the use of different preparations of DCF and different primary cell cultures in various experiments.
An antagonist of guanyl cyclase, ODQ, reverses the inhibitory effect of NO, relative to insulin-induced hydrogen peroxide elevation. To complement the aforementioned experiments, we tested the hypothesis that increased cGMP is necessary to mediate the inhibitory effect of NO on insulin-induced increase of hydrogen peroxide levels. ODQ is considered to be a selective inhibitor of NO-stimulated guanyl cyclase activity (14) . Treatment of cells with insulin or NO donor, in the absence or presence of ODQ, demonstrated that the latter agent could reverse the inhibitory effect of NO, without inducing an effect of its own (Fig. 5) . These results support the hypothesis that elevation of cGMP induced by NO is necessary to mediate its capacity to block the increase of hydrogen peroxide levels.
Insulin increases NADPH oxidase activity, via a mechanism that is blocked by NO or a cGMP analog. A major source of hydrogen peroxide in vascular smooth muscle cells has been reported to be the plasma membrane NAD(P)H oxidase system (15, 32) . To determine whether insulin has the capacity to activate this system in cultured rat aortic smooth muscle cells and to test the hypothesis that NO or cGMP attenuates hydrogen peroxide generation by targeting NADPH oxidase, we treated cells with or without insulin, in the absence or presence of NO or cGMP. As shown in Fig. 6 , insulin increased NADPH oxidase activity by about threefold, as measured by the increase of lucigenin chemiluminescence. 1 The magnitude of the effect of insulin was similar to that of PDGF, an established activator of reactive oxygen species generation in vascular cells (43) . Both NO and cGMP analog blocked the effect of insulin (Fig. 6) . Moreover, the NADPH oxidase inhibitor DPI decreased both basal and stimulated NADPH activities by Ͼ90% (results not shown). It is important to note that the activity measured in this assay represents NADPH-dependent oxidase, inasmuch as the lack of NADPH reduces activity levels by Ͼ99% (not shown). These observations support the hypothesis that NO targets insulin-stimulated NADPH oxidase via a cGMP-mediated mechanism.
NO attenuates insulin-or IGF-I-induced receptor phosphorylation via its capacity to decrease insulin-elevated hydrogen peroxide levels.
Insulin and IGF-I signaling pathways both involve tyrosine phosphorylation of their cognate receptors, as one of the early events in their signal transduction cascades. We (42) recently reported that NO attenuates insulin-stimulated IR tyrosine phosphorylation. To test the hypothesis that this effect is mediated via the capacity of NO to attenuate insulin-induced hydrogen peroxide elevation, we treated cells with insulin, in the presence or absence of catalase. As shown in Fig. 7 , catalase, but not boiled catalase, blocked insulin-induced receptor tyrosine phosphorylation, consistent with the view that the effect of insulin requires hydrogen peroxide elevation. We also tested the hypothesis that cGMP agonists would similarly attenuate insulin-induced receptor phosphorylation. As depicted in Fig. 7 , both cGMP and the NO donor DETANO blocked insulin-induced receptor phosphorylation. Data given in Fig. 8 show that IGF-I-induced IGF-IR phosphorylation was similarly attenuated by catalase, NO, or cGMP. To verify that the effect of catalase occurred via its capacity to reduce hydrogen peroxide levels derived from an oxidase, we determined the effect of the NAD(P)H oxidase inhibitor, DPI, on IR phosphorylation levels. As shown in Fig. 9 , DPI strongly attenuated insulin-induced IR phosphorylation levels, strengthening the view that both catalase and DPI elicit receptor dephosphorylation by decreasing hydrogen peroxide levels.
NO attenuates insulin-induced Akt phosphorylation. In a previous study, we (42) reported that NO attenuated the capacity of insulin to stimulate the MAP kinase pathway. It is well established that Akt phoshorylation is a downstream event on the pathway from insulin-induced receptor activation. To further verify that the events downstream from IR phosphorylation are suppressed by NO, we were prompted to determine the effect of NO donor on Akt phosphorylation. As shown in Fig. 10 , NO significantly attenuated the capacity of insulin to increase Akt phosphotyrosine levels. 
Catalase blocks insulin or IGF-I-induced cell motility.
The capacity of catalase to attenuate insulin or IGF-I-induced hydrogen peroxide elevation and receptor phosphorylation predicted that catalase would also block cell motility, if elevation of hydrogen peroxide were necessary for cell motility. To test this hypothesis, we treated cells with or without catalase, in the presence or absence of insulin or IGF-I. As depicted in Fig. 11 , catalase, but not boiled catalase, blocked insulin or IGF-Iinduced cell motility. To verify that the inhibitory effect of catalase on motility occurs via its capacity to decrease hydrogen peroxide levels via inhibition of an oxidase, we also measured the effect of a second inhibitor of hydrogen peroxide elevation, DPI. As depicted in Fig. 12 , DPI-induced marked attenuation of insulin-induced cell motility. These findings support the view that the motogenic effect of insulin requires upregulation of hydrogen peroxide levels.
NO-induced inhibition of cell motility is mediated via the cGMP pathway.
In a previous study, we (42) reported that NO attenuates insulin-stimulated rat aortic smooth muscle cell motility. The results shown in Fig. 13A confirm these findings. Furthermore, treatment of cells with cGMP analog mimics the effect of NO, supporting the hypothesis that the antimotogenic effect of NO is mediated via cGMP as the second messenger. Similar to the inhibition of the effect of insulin, the NO donor SNAP blocks IGF-I-stimulated cell motility (Fig. 13B) .
Treatment with hydrogen peroxide induces cell motility and reverses the inhibitory effect of cGMP. Experiments described above indicated that hydrogen peroxide upregulation is necessary for insulin-or IGF-I-induced cell motility. To determine whether an increase of hydrogen peroxide is sufficient to induce motility, we treated cells with increasing levels of hydrogen peroxide, both in the presence or absence of cGMP or insulin. These experiments were done using cGMP rather than NO as the inhibitor to avoid the potential complication of an interaction of exogenous hydrogen peroxide and NO. The results shown in Fig. 14 indicate that hydrogen peroxide alone increased cell motility in concentration-dependent fashion; moreover, hydrogen peroxide rescued the inhibitory effect of cGMP. Taken together, these results support the hypotheses that an increase of hydrogen peroxide is sufficient to explain the motogenic effect of insulin and that the decrease of hydrogen peroxide induced by cGMP agonists is both necessary and sufficient to explain the antimotogenic effect of NO.
DISCUSSION
Neointimal enlargement is a process that critically depends on vascular smooth muscle migration from the media. Vascular smooth muscle cell motility and proliferation have been reported to be under the reciprocal control of polypeptide growth factors such as PDGF, EGF, FGF, IGF-I, or insulin and agents that oppose the effect of these growth factors such as prostaglandins, heparin, NO or atrial natriuretic factor (11, 13, 25) .
The main purpose of this work was to test the overall hypothesis that the capacity of NO to block insulin-or IGF-Iinduced hydrogen peroxide elevation in cultured vascular smooth muscle cells can explain NO-induced inhibition of cell motility. The study was performed in primary cultures of vascular smooth muscle cells isolated from newborn rats for two reasons. First, these cells express relatively high levels of the presumed downstream cGMP effector PKG, compared with repetitively subcultured cells, which have a deficiency or lack of PKG (results not shown). Second, the cells express a cytoskeletal phenotype that resembles that found in neointimal cells (27) .
Our study is the first to show that NO targets one (or more) NAD(P)H oxidase(s) via a cGMP-mediated mechanism, followed by decrease of hydrogen peroxide levels, rather than via a direct effect, as reported in neutrophils (7, 12, 35) . The capacity of cGMP analog to inhibit insulin-stimulated NADPH oxidase activity strongly suggests that the decrease of hydrogen peroxide levels by cGMP agonists can be explained by inhibition of NADPH oxidase activity. It should also be noted, however, that our experiments do not identify a specific NADPH oxidase as the target of the cGMP pathway, inasmuch as several different enzymes have the capacity to generate superoxide and DPI is not a selective inhibitor of the plasma membrane NAD(P)H oxidase. Thus it is clear that additional work will be required to identify the specific enzyme(s) involved in this process. We also report the novel finding that the increase of hydrogen peroxide induced by either insulin or IGF-I is both sufficient and necessary to explain the mitogenic effect of these agents. Furthermore, the reduction of hydrogen peroxide is both necessary and sufficient to explain the capacity of NO to decrease insulin-or IGF-I-induced motility in cultured rat aortic smooth muscle cells.
Interestingly, the time course of hydrogen peroxide elevation induced by insulin was transient, whereas that induced by IGF-I was more sustained. The reasons for this difference are unknown, but they are consistent with the view that hydrogen peroxide induces upregulation of IGF-I mRNA levels, which could in turn stimulate an IGF-I-induced feed-forward mechanism involving the intermediacy of hydrogen peroxide (10) . Moreover, the transiency of insulin's effect indicates that a relatively short period of hydrogen peroxide elevation is sufficient to induce aortic smooth muscle cell motility.
Recent studies (29) have demonstrated unequivocally the presence of NAD(P)H oxidase in intact blood vessels. Moreover, NAD(P)H oxidase is recognized as the predominant system that generates superoxide in vascular smooth muscle (15, 32) . The NAD(P)H oxidase system has been reported to be upregulated in balloon injury or atherosclerosis and the activity of the enzyme has been linked to growth factor-induced cell proliferation (40, 43, 45) . Consistent with these data are findings that antioxidants have the capacity to attenuate neointima formation (38) . Previous studies have reported that NO can decrease superoxide generation in neutrophils via a direct interaction (7, 12, 35) , whereas the current results indicate a requirement for the cGMP pathway. Events donwstream from cGMP may include activation of PKG and reduction of cytoplasmic Ca 2ϩ , but this remains to be documented. Speculatively, a reduction of cytoplasmic Ca 2ϩ by NO via the cGMP/PKG pathway (8, 17) can explain the current results because there is evidence that implicates Ca 2ϩ as a regulator of NADPH oxidase (6, 9) . Moreover, reduced Ca 2ϩ is likely to be associated with reduced PKC activity and PKC has been reported to be involved in regulation of NADPH activity (6) .
Other investigators have found that NO can directly interact with superoxide, forming peroxynitrite, a strong oxidant that can also induce oxidation of the reporter dye DCF (22) . However, it is unlikely that addition of NO to our cells would generate significant amounts of peroxynitrite, because this would have increased, not decreased, the levels of oxidized DCF, as reported previously (22) . Moreover, the capacity of cGMP to block hydrogen peroxide elevation and motogenesis, and that of ODQ to reverse the inhibitory effect of NO, argues against an involvement of peroxynitrite in explaining our results.
An emerging link between reactive oxygen species and cellular regulation is the inhibitory effect of hydrogen peroxide on protein tyrosine phosphatase activity. Thus elevation of hydrogen peroxide by insulin or EGF is associated with decreased activity of at least one important phosphatase, namely PTP1B (24) . A recently proposed mechanism that can account for the phosphatase inhibitory effect of hydrogen peroxide is oxidation of a catalytically essential cysteine residue, present in most if not all such phosphatases (34) . We have reported that NO attenuates the phosphorylation of the IR by inducing activation of PTP1B (42) , and in the current study we have found similar results relative to IGF-IR in IGF-I-stimulated cells. Because PTP1B can directly target the insulin and IGF-I receptors (4, 48) , it seems likely that inhibition of PTP1B by hydrogen peroxide contributes to increased tyrosine phosphorylation of the transmembrane insulin or IGF-I receptors; reciprocally, the decrease of hydrogen peroxide levels by NO would then contribute to increasing PTP1B activity and maintaining the phosphorylation of receptors at low levels. These events would then contribute to attenuating insulin/IGF-I-induced signal transduction, as shown by the capacity of NO to attenuate Akt phosphorylation (current study) and MAP kinase activity (42) .
In summary, we report novel data indicating that NO targets the NAD(P)H oxidase, via a cGMP-dependent mechanism that attenuates the capacity of insulin or IGF-I to increase hydrogen peroxide levels. The suppression of hydrogen peroxide is both necessary and sufficient to explain the antimotogenic effect of NO in differentiated rat aortic smooth muscle cells. Finally, it is interesting to note the existence of an inverse relationship between NO and superoxide levels in human vascular tissues (16) . Taken together, these studies raise the possibility that NO could act as agonist of a counterregulatory pathway that decreases the generation of reactive oxygen species, thus functioning as endogenous antioxidant in vascular smooth muscle. The mechanisms described in our report are likely to be of relevance to in vivo events and the testing of this hypothesis is now in progress.
